Exelixis (EXEL) Share-based Compensation Growth (5y) (2015 - 2026)
Exelixis (EXEL) Share-based Compensation Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 44.46% |
| Jan 2, 2026 | 98.75% |
| Apr 4, 2025 | 10.00% |
| Sep 27, 2024 | 119.35% |
| Jun 28, 2024 | 15.88% |
| Mar 29, 2024 | 8.81% |
| Dec 29, 2023 | 10.19% |
| Sep 29, 2023 | -17.74% |
| Jun 30, 2023 | 67.08% |
| Mar 31, 2023 | 3.73% |
| Dec 30, 2022 | 34.32% |
| Sep 30, 2022 | 48.55% |
| Jul 1, 2022 | -66.79% |
| Apr 1, 2022 | 66.53% |
| Dec 31, 2021 | 35.50% |
| Jul 2, 2021 | -15.36% |
| Apr 2, 2021 | 23.24% |
| Apr 3, 2020 | 53.14% |
| Sep 27, 2019 | 5.54% |
| Jun 28, 2019 | -35.31% |